Keith L. Crandell has served on the 908 Devices board since June 2012. He is a co-founder and managing director of ARCH Venture Partners, an early-stage technology venture capital firm, where he has worked since July 1994. He serves on the board of Twist Bioscience and previously served on the board of Quanterix. He holds a B.S. in chemistry and mathematics from St. Lawrence University, an M.S. in chemistry from the University of Texas at Arlington, and an MBA from the University of Chicago.